// April 17, 2023
USP’s Preferential Access for Regulators (PAR) Program: Supporting the Global Supply of Quality Medicines
In the U.S. and around the world, quality standards developed by the U.S.
In the U.S. and around the world, quality standards developed by the U.S.
For patients needing a bone marrow or stem cell transplant, successful treatment often depends on
USP’s Healthcare Quality Expe
The Root Causes of Substandard Medicines in Lower and Middle Income Countries (LMICs)